Status:
UNKNOWN
Apatinib in Advanced Non-squamous，NSCLC
Lead Sponsor:
Jian Fang
Collaborating Sponsors:
The Second Affiliated Hospital of Harbin Medical University
Peking University Third Hospital
Conditions:
Non-squamous Non-Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
To explore the efficacy and safety of apatinib in non-squamous non-small cell lung cancer in the real-world.
Detailed Description
This is a multi-center, non-interventional clinical study. The number of patients that planned to be recruited is: from May 2017 to April 2019, the actual number of cases recruited into this study. I...
Eligibility Criteria
Inclusion
- Age: ≥ 18 years old;
- Histologically or cytologically confirmed, locally advanced or stage IV non-squamous, non-small cell lung cancer;
- Regardless of the past anti-tumor treatments (no limited to the number of past treatment lines), the doctors believe that apatinib can bring benefits to patients;
- The patient is voluntarily to join the study, and signed informed consent, good compliance, with follow-up.
Exclusion
- If any of the following criteria is met, the subject shall be excluded:
- Squamous cell carcinoma and/or small cell lung cancer patients;
- There are contraindications to apatinib (active bleeding, thrombosis, ulcers, intestinal perforation, intestinal obstruction, uncontrollable hypertension, grade III-IV cardiac insufficiency, major surgery within 30 days, severe liver and kidney dysfunction, etc.);
- Allergic to apatinib and / or its excipients;
- Pregnant or lactating women;
- According to the researcher's judgment, there are other situations that may increase the risk associated with participating in this study or the drug, which may lead to patients not being eligible for enrollment in the study.
Key Trial Info
Start Date :
May 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2019
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03376191
Start Date
May 1 2017
End Date
October 1 2019
Last Update
December 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142